MedPath

Evaluation of blood counts(platelet values) done routinely in pregnant women with high BP recordings and assessing the severity by comparing with the normal pregnant women .

Not Applicable
Conditions
Health Condition 1: null- Pregnant women with pre-eclampsia as cases and healthy pregnant women as controls.
Registration Number
CTRI/2017/11/010606
Lead Sponsor
Dr Shifali R
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Cases:- Pregnant woman more than 20 weeks of gestation who are booked cases

in KH, manipal with BP > 140/90mmhg on two measurements taken 6 hours

apart, with Proteinuria of more than 300 mg in 24 hours urine were included in

the pre-eclampsia group.

Control :- Healthy pregnant women with similar demographic age will be included

in the study as a control group.

Exclusion Criteria

Multiple pregnancy

Morbid obesity ( BMI> 40)

Intrauterine fetal death

Poor past obstetric history

Medical disorders (chronic hypertension, diabetes mellitus,

diseases, renal diseases, hepatic dysfunction

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) To study the variation of platelet indices in pre-eclampsia patients. <br/ ><br>2) To compare the platelet indices between the normal and pre-eclampsia <br/ ><br>patients. <br/ ><br>3) To assess the relationship between severity of pre-eclampsia and platelet <br/ ><br>indices and whether these indices can be used as a prognostic marker.Timepoint: 1 Year
Secondary Outcome Measures
NameTimeMethod
Pre- eclampsia continues to be the major cause of maternal and perinatal <br/ ><br>mortality. So there is a constant search for better prognostic factors to predict the progression and severity of the disease.Timepoint: 1 Year
© Copyright 2025. All Rights Reserved by MedPath